More recent protocols and community research have pushed starting doses even lower, with many beginning at 0.5 mg per week
It may be related to reduced calorie intake, dehydration, or drops in blood pressure, all of which can occur during the early weeks of treatment." "If dizziness continues beyond the initial adjustment phase, worsens at higher doses, or interferes with daily activities, a clinician should review blood pressure, hydration status, and any other medicines you are taking
Signs of an allergic reaction can include itchiness, a rash, hives, chest tightness, shortness of breath, and swelling of the throat, lips, mouth, or tongue
Tesamorelin has evidence for a narrow approved use, MOTS-C treatment evidence remains mostly preclinical, and retatrutide is still investigational